PERFORMANCE OF A NEW RISK ASSESSMENT TOOL FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY IN THE TARGETED THERAPY ERA: REMARCC SCORE


Carmen Mir M., Marchioni M., Campi R., Minervini A., Roussel E., Albertsen M., et al.

Annual Meeting of the American-Urological-Association (AUA), Washington, Kiribati, 15 - 18 Mayıs 2020, cilt.203

  • Cilt numarası: 203
  • Basıldığı Şehir: Washington
  • Basıldığı Ülke: Kiribati